Researchers in the UK have designed an AI-designed mRNA vaccine that protected mice and ferrets from severe disease after infection with bird flu viruses, which could benefit both animal and human health by supporting pandemic preparedness.
Bird flu is caused by infection with influenza A viruses and easily spreads around the world through birds’ migration routes. The infection can be lethal to animals, particularly poultry, and although some infections in humans have been mild, others have caused severe disease and mortality. Available vaccines are designed for past strains of influenza viruses, which evolve rapidly, and have limited efficacy.
Researchers from the University of Cambridge and the biotechnology company DIOSynVax Ltd, both in the UK, used AI to analyse the genetic diversity of circulating virus strains and design a target for the vaccine that, without matching any strain exactly, represented key features of many. The team had used the same technology earlier this year to develop vaccines against multiple coronaviruses, which proved safe in humans, and against human and swine flu viruses.
The AI-designed sequence was used to produce an mRNA vaccine. When exposed to three distinct bird flu viruses, all vaccinated mice survived (100%), compared with 100%, 67% and 50% survival of mice given a conventional vaccine and infected with the same strains. Four days after infection, vaccinated mice had no visible viruses in their lungs and spleens. Five out of six vaccinated ferrets survived compared with three out of six vaccinated with the conventional vaccine.
"If we can make better animal vaccines, then we can better protect human health as well," said Jonathan Heeney, researcher at Cambridge and leader of the study published in Cell Reports Medicine.
Future work includes testing the new bird flu vaccine in human clinical trials and using the same technology to design vaccines for diseases such as Ebola, Lassa fever and Marburg.